LivaNova PLC to Present at the Credit Suisse Annual Healthcare Conference
October 24 2016 - 9:00AM
LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (“LivaNova” or the
“Company”), a market-leading medical technology and innovation
company, today announced that André-Michel Ballester, Chief
Executive Officer of LivaNova, and Vivid Sehgal, Chief Financial
Officer of LivaNova, will both be participating in a discussion at
the Credit Suisse Healthcare Conference on Tuesday, November 8,
2016.
The discussion is scheduled to begin at 11:00
a.m. Mountain Standard Time on Tuesday, November 8, 2016. It
will be available to all interested parties through a live
audiocast accessible via the investor relations section of
LivaNova's website at www.livanova.com. Listeners should log
on approximately 10 minutes in advance to ensure proper setup to
receive the audiocast. A replay of the webcast will be
available on the LivaNova website approximately 24 hours after the
live presentation for 90 days after the event.
About LivaNovaLivaNova PLC is a
global medical technology company formed by the merger of Sorin
S.p.A, a leader in the treatment of cardiovascular diseases, and
Cyberonics Inc., a medical device company with core expertise in
neuromodulation. LivaNova transforms medical innovation into
meaningful solutions for the benefit of patients, healthcare
professionals, and healthcare systems.
The Company employs approximately 4,600
employees worldwide and is headquartered in London, U.K.
For more information, please visit
www.livanova.com, or contact: Investor Relations
and Media Karen King Vice President,
Investor Relations & Corporate Communications Phone: +1 (281)
228-7262 Fax: +1 (281) 218-9332 e-mail:
corporate.communications@livanova.com
Livanova (LSE:LIVN)
Historical Stock Chart
From Apr 2024 to May 2024
Livanova (LSE:LIVN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Livanova (London Stock Exchange): 0 recent articles
More News Articles